Global, Regional and National Incidence and Case-fatality rate of Novel Coronavirus (COVID-19) across 154 countries and territories: A systematic assessment of cases reported from January to March 16, 2020
Bhagavathula, A. S.; Rahmani, J.; Aldhaleei, W. A.; Rovetta, A.
Show abstract
BackgroundThe 2019 novel coronavirus disease (COVID-19) outbreak turned into a pandemic, with hundreds of thousands of cases reported globally. The number of cases dramatically increased beginning in early March 2020. AimWe assessed the cumulative change in the incidence and case-fatality rates of COVID-19 at the global, regional, and national levels from January to March 16, 2020, in 154 affected countries and territories globally. MethodsWe collected data of COVID-19 cases using the GitHub repository, which provided real-time surveillance information developed by the Center for Systems Science and Engineering (CSSE), Johns Hopkins University (USA). Information such as confirmed COVID-19 cases, deaths, and recoveries reported across all affected countries was collected from January 22 to March 16, 2020. We estimated the change in the incidence rate, case-fatality rate, and recovery rate from January 22 to February 29 and from March 1 to March 16, 2020. ResultsFrom January 22 to March 16, 2020, globally, the number of incident COVID-19 cases increased by 276.2%, and Europe recorded 65,281 new cases from March 1 to 16, 2020. Overall, the case-fatality rate was 3.92%, with a high COVID-19 fatality rate in Italy (7.7%), Iran (5.7%), China (4.2%) and the United Kingdom (3.6%). The estimated percentage change in COVID-19 cases from March 1 to 16, 2020, was highest in Belgium (105.8/100,000 population), followed by Qatar (439/100,000 population) and Portugal (331/100,000 population). The overall recovery rate of COVID-19 was 43%; China (35.5%) had the highest recovery rate, while the United States of America recorded a recovery rate of 0.3%. ConclusionOverall, all the COVID-19-affected countries showed an upward trend in incidence, with little change in the incidence rate of -0.20% from January to Mid-March. The case-fatality rate was found to be 3.92%, and the recovery rate was observed to be less than half (43%) among COVID-19 patients. Italy, Iran, and Spain had the largest numbers of new cases of COVID-19 from March 1 to 16, 2020.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Monitoring Disease Transmissibility of 2019 Novel Coronavirus Disease in Zhejiang, China 94%
- Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020 94%
- Live poultry feeding and trading network and the transmission of avian influenza A(H5N6) virus in a large city in China, 2014-2015 94%
Similar papers in this journal
- The impact of armed conflict on the epidemiological situation of Coronavirus disease (COVID-19) in Libya, Syria, and Yemen 94%
- Stay-at-home and face mask policies intentions inconsistent with incidence and fatality during US COVID-19 pandemic 94%
- Health Economic Burden of COVID-19 in Saudi Arabia 93%
Similar papers in this journal
- Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey 93%
- Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China 93%
- Clinical characteristics of Coronavirus Disease 2019 (COVID-19) patients in Kuwait 93%
Similar papers in this journal
- Studies of Novel Coronavirus Disease 19 (COVID-19) Pandemic: A Global Analysis of Literature 93%
- The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection 92%
- Research on the Influence of Information Diffusion on the Transmission of the Novel Coronavirus (COVID-19) 91%
Similar papers in this journal
- Explanation of Hand, Foot, and Mouth Disease Cases in Japan Using Google Trends Before and During the COVID-19: Infodemiology Study 93%
- Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico 93%
- The Long-Term Impact of COVID-19 Non-Pharmaceutical Interventions on Notifiable Infectious Diseases in Poland: A Comprehensive Analysis from 2014-2022 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.